Characterization of KISS1R, a G protein Coupled Receptor in Reproduction

生殖中 G 蛋白偶联受体 KISS1R 的表征

基本信息

  • 批准号:
    9069913
  • 负责人:
  • 金额:
    $ 13.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-07-01 至 2017-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The activation of gonadotropin-releasing hormone (GnRH) neurons at puberty is not well understood but recent evidence suggests a role for the kisspeptin-KISS1R system as a key regulator of reproductive development and function. While it is clear that kisspeptin and KISS1R function as essential regulators of the neuroendocrine cascade, many questions remain about the role of this novel ligand-receptor system in the regulation of GnRH neuronal function at the time of puberty as well as during subsequent reproductive function. The overarching hypothesis underlying this project is that intracellular signal transduction by kisspeptin is influenced by desensitization, internalization, and recycling/degradation of the KISS1R, thereby playing critical roles in controlling the timing of puberty and maintaining cyclical reproductive function. An additional hypothesis for this project is that a better understanding of the mechanisms by which mutations affect the kisspeptin-KISS1R system will have clinical implications by providing insights into the pathophysiology of the associated phenotypes, laying the groundwork for the development of new diagnostic tools as well as for genetic counseling of patients and their family members, and identifying novel therapeutic targets. We propose the following specific aims: (1) To characterize KISS1R-mediated intracellular signaling, trafficking, turnover, desensitization, and resensitization; (2) To identify extracellular co-factors that modulate KISS1R signaling and to study their mechanisms of action in the regulation of kisspeptin-mediated KISS1R activation; and (3) To generate and characterize a KISS1R (R386P) knock-in mouse as a model to better understand the mechanisms by which this mutation is associated with central precocious puberty (CPP). The successful completion of the proposed studies will advance our understanding of the kisspeptin/KISS1R system in the regulation of GnRH neuronal function at the time of puberty as well as during subsequent reproductive function and discover potential therapeutic targets for patients with reproductive disorders. Furthermore, completion of these studies will provide training in the generation of genetically manipulated mouse models and will enrich the Candidate's research experience in experimental design, aiding in the development of a successful independent translational investigator.
描述(由申请人提供):青春期促性腺激素释放激素 (GnRH) 神经元的激活尚不清楚,但最近的证据表明 Kisspeptin-KISS1R 系统作为生殖发育和功能的关键调节剂的作用。虽然很明显 Kisspeptin 和 KISS1R 是神经内分泌级联的重要调节剂,但这种新型配体-受体系统在青春期以及随后的生殖功能期间 GnRH 神经元功能调节中的作用仍然存在许多问题。该项目的总体假设是 Kisspeptin 的细胞内信号转导受到 KISS1R 脱敏、内化和回收/降解的影响,从而在控制青春期时间和维持周期性生殖功能方面发挥关键作用。该项目的另一个假设是,更好地了解突变影响 Kisspeptin-KISS1R 系统的机制将具有临床意义,可以深入了解相关表型的病理生理学,为开发新的诊断工具以及患者及其家庭成员的遗传咨询奠定基础,并确定新的治疗靶点。我们提出以下具体目标:(1)表征KISS1R介导的细胞内信号传导、运输、周转、脱敏和再敏化; (2) 鉴定调节KISS1R信号传导的细胞外辅助因子并研究其在调节Kisspeptin介导的KISS1R激活中的作用机制; (3) 生成并表征 KISS1R (R386P) 敲入小鼠作为模型,以更好地了解该突变与中枢性性早熟 (CPP) 相关的机制。拟议研究的成功完成将加深我们对 Kisspeptin/KISS1R 系统在青春期以及随后的生殖功能期间 GnRH 神经元功能调节的理解,并为生殖障碍患者发现潜在的治疗靶点。此外,这些研究的完成将为生成基因操纵小鼠模型提供培训,并将丰富候选人在实验设计方面的研究经验,有助于培养一名成功的独立转化研究者。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Reversal of idiopathic hypogonadotropic hypogonadism: a cohort study in Chinese patients.
特发性性疾病性性低肿瘤的逆转:中国患者的一项队列研究。
  • DOI:
    10.4103/1008-682x.145072
  • 发表时间:
    2015-05
  • 期刊:
  • 影响因子:
    2.9
  • 作者:
    Mao JF;Xu HL;Duan J;Chen RR;Li L;Li B;Nie M;Min L;Zhang HB;Wu XY
  • 通讯作者:
    Wu XY
Anti-PD1 following ipilimumab for mucosal melanoma: durable tumor response associated with severe hypothyroidism and rhabdomyolysis.
  • DOI:
    10.1158/2326-6066.cir-13-0146
  • 发表时间:
    2014-01
  • 期刊:
  • 影响因子:
    10.1
  • 作者:
    Min L;Hodi FS
  • 通讯作者:
    Hodi FS
Immune-related endocrine disorders in novel Immune checkpoint inhibition therapy.
  • DOI:
    10.1016/j.gendis.2016.10.002
  • 发表时间:
    2016-12
  • 期刊:
  • 影响因子:
    6.8
  • 作者:
    Min L
  • 通讯作者:
    Min L
Unique Cytologic Features of Thyroiditis Caused by Immune Checkpoint Inhibitor Therapy for Malignant Melanoma.
  • DOI:
    10.1016/j.gendis.2017.11.002
  • 发表时间:
    2018-03
  • 期刊:
  • 影响因子:
    6.8
  • 作者:
    Angell TE;Min L;Wieczorek TJ;Hodi FS
  • 通讯作者:
    Hodi FS
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Le Min其他文献

Le Min的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Le Min', 18)}}的其他基金

Characterization of KISS1R, a G Protein Coupled Receptor in Reproduction
生殖中 G 蛋白偶联受体 KISS1R 的表征
  • 批准号:
    8225821
  • 财政年份:
    2012
  • 资助金额:
    $ 13.8万
  • 项目类别:
Characterization of KISS1R, a G protein Coupled Receptor in Reproduction
生殖中 G 蛋白偶联受体 KISS1R 的表征
  • 批准号:
    8857521
  • 财政年份:
    2012
  • 资助金额:
    $ 13.8万
  • 项目类别:
Characterization of KISS1R, a G protein Coupled Receptor in Reproduction
生殖中 G 蛋白偶联受体 KISS1R 的表征
  • 批准号:
    8448075
  • 财政年份:
    2012
  • 资助金额:
    $ 13.8万
  • 项目类别:
Characterization of KISS1R, a G protein Coupled Receptor in Reproduction
生殖中 G 蛋白偶联受体 KISS1R 的表征
  • 批准号:
    8681490
  • 财政年份:
    2012
  • 资助金额:
    $ 13.8万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
  • 批准号:
    24K12256
  • 财政年份:
    2024
  • 资助金额:
    $ 13.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
  • 批准号:
    24K19176
  • 财政年份:
    2024
  • 资助金额:
    $ 13.8万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
  • 批准号:
    10578068
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
  • 批准号:
    10933287
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
  • 批准号:
    10650593
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
  • 批准号:
    10649275
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
  • 批准号:
    10734158
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
  • 批准号:
    10784209
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
  • 批准号:
    10580259
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
Fentanyl Addiction: Individual Differences, Neural Circuitry, and Treatment with a GLP-1 Receptor Agonist
芬太尼成瘾:个体差异、神经回路和 GLP-1 受体激动剂治疗
  • 批准号:
    10534864
  • 财政年份:
    2023
  • 资助金额:
    $ 13.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了